SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,892.95 13.55
( 0.02%)

Global Indices

Nasdaq

52,502.29 249.40
(0.48%)

Dow Jones

7,647.48 105.55
(1.40%)

Hang Seng

60,763.20 -485.39
(-0.79%)

Nikkei 225

10,823.18 71.59
(0.67%)

Forex

USD-INR

93.57 -0.21
(-0.22%)

EUR-INR

104.78 -0.12
(-0.12%)

GBP-INR

125.37 -0.34
(-0.27%)

JPY-INR

0.59 0.00
(-0.40%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

97.3802066

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

130.31

454913.91

EPS(TTM)

Face Value()

Div & Yield %

14.55

0.84

Back

Indosolar standalone net profit declines 89.17% in the September 2026 quarter

Oct 22,2026

Net profit of Indosolar declined 89.17% to Rs 5.02 crore in the quarter ended September 2026 as against Rs 46.34 crore during the previous quarter ended September 2025. Sales declined 23.18% to Rs 155.59 crore in the quarter ended September 2026 as against Rs 202.55 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	155.59	202.55	-23
OPM %	9.53	34.92	-
PBDT	16.34	70.36	-77
PBT	6.71	61.14	-89
NP	5.02	46.34	-89

81,892.95 13.55 ( 0.02%)

52,502.29 249.40 (0.48%)

7,647.48 105.55 (1.40%)

60,763.20 -485.39 (-0.79%)

10,823.18 71.59 (0.67%)

93.57 -0.21 (-0.22%)

104.78 -0.12 (-0.12%)

125.37 -0.34 (-0.27%)

0.59 0.00 (-0.40%)